Topic Teaching

Warfarin Reversal with Prothrombin Complex Concentrates and Challenges of the New Oral Anticoagulants.

Date: 
juin 11, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Irene Sadek

Clinical Impact of Red Cell Storage Time: the ARIPI Study

Date: 
mai 7, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dean Fergusson, MHA, PhD

  1. Understand the evidence-base for the effects  of red cell storage age in the critically ill
  2. Learn about the clinical  impact of storage age in a neonatal critical care population
  3. Learn about ongoing and future research assessing red cell storage age

Maternal-Fetal Tranfusion Medicine

Date: 
avril 23, 2013
Heure: 
12:00 - 1:00 p.m.
Location: 
Mount Sinai Hospital- Ben Sadowski Auditorium, 18th Floor

Principles of Therapeutic Apheresis: A Method to the Madness

Date: 
avril 9, 2013
Heure: 
12:00 - 1:00 Eastern
Location: 
1-866-752-7690
Speaker(s): 
Dr. Paul Yenson

Objectives:

• Describe the abbreviated history of therapeutic apheresis.
• List 2 different methods of blood separation.
• Discuss the physiologic effects of therapeutic apheresis, including
anticoagulation, fluid balance, plasma dilution and cellular loss.
• List the most common indications and side effects of therapeutic
apheresis.
• Describe an approach to a therapeutic apheresis consultation.

Transfusions at the end of life: Ethical Considerations

Date: 
avril 2, 2013
Heure: 
12:00 - 1:00 Eastern
Location: 
1-866-752-7590 ID 1775282
Speaker(s): 
Blair Henry

Objectives:
1) Identify key ethical principles involved in the allocation/limiting of blood products in critically ill patients at the end of life
2) Discuss concepts of futility in regards to use of blood products
3) Clinical Framework for bedside resource limit setting

References:
1) Smith, L. B., Cooling, L. and Davenport, R. (2012), How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines. Transfusion. doi: 10.1111/j.1537-2995.2012.03658.x

Quality Blood

Date: 
mars 26, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282

Donor Testing

Date: 
mars 12, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Objectives:
1.      Understand the different components of blood safety as it pertains to prevention of infectious disease transmission.
2.      Understand the concept of residual risk, how it is calculated and know the estimates for the major viral pathogens at CBS.

Coagulation Factor Inhibitors

Date: 
février 26, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Shannon Jackson
Objectives:
1.    To discuss the epidemiology, mechanism, and risk factors for inhibitors in inherited bleeding disorders and inhibitors causing acquired bleeding disorders.
2.    Review the management of inhibitors using bypassing agents.

Transfusion Mnagement of Hemoglobinopathies

Date: 
février 12, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Kevin Kuo
Objectives:
·         Examine the evidence (or the lack of) on the use of transfusion in the treatment and prevention of sickle cell complications

Acute Adverse Reactions to Transfusion: A Symptoms-Based Approach

Date: 
janvier 29, 2013
Heure: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Kathryn Webert
Objectives:
·         Develop a practical approach to diagnosis and management of acute transfusion reactions based on common presenting symptom
Syndicate content

Text will be replaced with image replacement